Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease

Alzheimers Dement. 2021 Jan;17(1):115-124. doi: 10.1002/alz.12192. Epub 2020 Oct 19.

Abstract

The etiology of the common, sporadic form of Alzheimer's disease (sAD) is unknown. We hypothesize that tau pathology within select projection neurons with susceptible microenvironments can initiate sAD. This postulate rests on extensive data demonstrating that in human brains tau pathology appears about a decade before the formation of Aβ plaques (Aβps), especially targeting glutamate projection neurons in the association cortex. Data from aging rhesus monkeys show abnormal tau phosphorylation within vulnerable neurons, associated with calcium dysregulation. Abnormally phosphorylated tau (pTau) on microtubules traps APP-containing endosomes, which can increase Aβ production. As Aβ oligomers increase abnormal phosphorylation of tau, this would drive vicious cycles leading to sAD pathology over a long lifespan, with genetic and environmental factors that may accelerate pathological events. This hypothesis could be testable in the aged monkey association cortex that naturally expresses characteristics capable of promoting and sustaining abnormal tau phosphorylation and Aβ production.

Keywords: abnormally phosphorylated tau; association cortex; calcium; rhesus monkey; sporadic Alzheimer's disease; tau seeding; β-amyloid.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging / pathology
  • Alzheimer Disease / pathology*
  • Animals
  • Brain / pathology
  • Humans
  • Macaca mulatta
  • Middle Aged
  • Tauopathies / pathology*
  • tau Proteins*

Substances

  • MAPT protein, human
  • tau Proteins